GO:0070383 DNA cytosine deamination: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070383 DNA cytosine deamination is the biological process that removes an amino group from a cytosine residue in DNA, converting it to uracil.
• Spontaneous deamination of cytosine to uracil is biased to the non-transcribed DNA strand in yeast, linking transcription and DNA repair.
• Enzymatic cytosine deamination is carried out by diverse proteins including AID, APOBEC3G, SssI DNA methyltransferase, and bacterial toxins DddA and SsdA.
• DNA cytosine deamination generates uracil lesions that are substrates for base excision repair and can lead to C-to-T transition mutations if unrepaired.
• Structural studies reveal sequence-specific and sequence-context-independent mechanisms for double-stranded and single-stranded DNA cytosine deamination.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable functional dissection of deaminases and their roles in immunity, cancer, and genome editing.
Description
DNA cytosine deamination (GO:0070383) is a fundamental biological process in which a cytosine residue in DNA loses its amino group and becomes uracil. This reaction occurs both spontaneously, through hydrolytic deamination, and enzymatically, catalyzed by specialized deaminase enzymes that target DNA. The resulting uracil is a non-canonical base that must be recognized and processed by cellular repair machinery to maintain genomic integrity. Because cytosine deamination can drive C-to-T transition mutations, it is a central mechanism in mutagenesis, immune diversification, and genome editing technologies. Researchers study this process to understand mutagenesis, DNA repair, and the molecular arms race between hosts and pathogens. The reaction is also exploited in biotechnology, as seen in base editors that use cytidine deaminase domains to install precise C-to-T changes in genomes. Thus, GO:0070383 encompasses a chemically simple but biologically profound modification that impacts genetics, immunology, and therapeutic development.
DNA cytosine deamination At A Glance
| GO ID | GO:0070383 |
|---|---|
| GO term | DNA cytosine deamination |
| Ontology | biological_process |
| Synonym | none |
| Definition | The removal of an amino group from a cytosine residue in DNA, forming a uracil residue. |
| Major function | Conversion of cytosine to uracil in DNA, generating a mutagenic lesion or an intermediate in immune diversification and genome editing. |
| Related enzymes | AID, APOBEC3G, SssI DNA methyltransferase, DddA, SsdA |
| Repair pathway | Base excision repair (uracil-DNA glycosylase initiated) |
| Mutational outcome | C-to-T transition mutations if unrepaired |
What Is GO:0070383?
According to the Gene Ontology, DNA cytosine deamination (GO:0070383) is the removal of an amino group from a cytosine residue in DNA, forming a uracil residue. This process can occur spontaneously or be catalyzed by enzymes, and it represents a chemical modification of DNA that alters base-pairing properties and can lead to mutations if not repaired.
Why Is DNA cytosine deamination Important in Cell Biology?
DNA cytosine deamination is critically important because it is a major source of spontaneous and enzymatic C-to-T mutations, which are among the most common mutations in cancer and genetic diseases. It also plays essential roles in immune diversification, as activation-induced cytidine deaminase (AID) and APOBEC3G deaminate cytosine in DNA to initiate somatic hypermutation and antibody diversification. In biotechnology, engineered cytidine deaminases are the catalytic core of base editors, enabling precise C-to-T genome editing with therapeutic potential. Understanding the mechanisms, regulation, and structural basis of cytosine deamination is therefore central to cancer biology, immunology, and gene therapy.
• Spontaneous cytosine deamination is a frequent endogenous DNA lesion that can cause C-to-T transition mutations.
• Enzymatic cytosine deamination by AID and APOBEC3G is essential for antibody diversification and retroviral restriction.
• Bacterial toxins DddA and SsdA deaminate cytosine in double-stranded and single-stranded DNA, respectively, with distinct structural mechanisms.
• SssI DNA methyltransferase can catalyze cytosine-to-uracil deamination, linking DNA methylation to mutagenesis.
• Unrepaired uracil lesions are mutagenic and are implicated in cancer and aging.
• Cytosine deamination is exploited in base editors for therapeutic genome editing.
• Heat-induced deamination of cytosine is influenced by DNA methylation status.
• Single-molecule sequencing reveals DNA mismatch and damage patterns including deamination events.
• Deamination bias to the non-transcribed strand in yeast links transcription to repair.
• Structural insights into deaminases inform inhibitor and editor design.
What Happens During DNA cytosine deamination?
Substrate recognition and binding
In simple terms: The enzyme finds and holds onto a cytosine base in DNA.
Deaminases must locate their target cytosine within the DNA helix. Structural studies of the bacterial toxin DddA reveal a sequence-specific recognition mechanism for double-stranded DNA, where the enzyme inserts a loop to flip the target cytosine out of the helix. In contrast, SsdA deaminates single-stranded DNA in a sequence-context-independent manner, using a distinct structural architecture. AID and APOBEC3G also bind single-stranded DNA and exhibit preferences for certain sequence motifs. SssI DNA methyltransferase, normally a methyltransferase, can also bind DNA and catalyze deamination under certain conditions.
Catalytic deamination reaction
In simple terms: The amino group is removed from cytosine, turning it into uracil.
The deamination reaction involves the hydrolytic removal of the exocyclic amino group from cytosine, yielding uracil and ammonia. This can occur spontaneously via hydrolysis, with heat accelerating the reaction. Enzymatic deamination by AID and APOBEC3G uses a zinc-dependent catalytic mechanism to activate water for nucleophilic attack. DddA and SsdA also employ catalytic residues to perform deamination on double-stranded and single-stranded DNA, respectively. SssI DNA methyltransferase can catalyze cytosine-to-uracil deamination, possibly through a similar mechanism involving base flipping.
Strand bias and transcription coupling
In simple terms: Deamination happens more often on one DNA strand, especially the one not being transcribed.
In yeast, spontaneous deamination of cytosine to uracil is biased to the non-transcribed DNA strand. This strand bias is thought to arise from transcription-coupled repair mechanisms that preferentially repair the transcribed strand, leaving more lesions on the non-transcribed strand. This observation links transcription, DNA repair, and mutagenesis, and has implications for understanding mutational signatures in cancer.
Repair and mutagenic consequences
In simple terms: If the uracil is not fixed, it can cause a mutation.
Uracil in DNA is recognized by uracil-DNA glycosylase and removed via base excision repair. If repair fails before DNA replication, the uracil pairs with adenine, leading to a C-to-T transition mutation in one daughter strand. Single-molecule sequencing has revealed patterns of DNA mismatch and damage, including deamination events, providing insights into mutagenesis. In immune cells, AID-induced deamination is intentionally coupled to error-prone repair to generate antibody diversity.
Regulation and cellular context
In simple terms: Cells control when and where deamination happens.
Deaminase activity is tightly regulated to avoid unwanted mutations. AID expression is restricted to activated B cells, and its activity is controlled by phosphorylation, subcellular localization, and interaction partners. APOBEC3G is packaged into virions and counteracted by HIV Vif, which targets it for degradation. Bacterial toxins like DddA and SsdA are expressed in specific contexts, and their activity may be regulated by antitoxins or environmental cues. SssI methyltransferase activity is linked to DNA methylation status, which can influence deamination rates.
Key Genes Involved in GO:0070383 DNA cytosine deamination
The following genes and proteins are directly implicated in DNA cytosine deamination or its regulation, as supported by the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| AICDA (AID) | Activation-induced cytidine deaminase; deaminates cytosine in single-stranded DNA during somatic hypermutation and class-switch recombination | Key enzyme for antibody diversification; studied in immunology and lymphoma |
| APOBEC3G | Deaminates cytosine in single-stranded DNA of retroviruses, restricting HIV-1 infectivity | Antiviral defense; counteracted by HIV Vif; target for antiviral research |
| DddA | Double-stranded DNA deaminase toxin from Burkholderia; sequence-specific cytosine deamination | Structural model for dsDNA deamination; used in base editors |
| SsdA | Single-stranded DNA cytosine deaminase toxin; sequence-context-independent | Structural insights into ssDNA deamination; potential biotech tool |
| SssI (M.SssI) | DNA methyltransferase that can also catalyze cytosine-to-uracil deamination | Links DNA methylation to mutagenesis; model for studying deamination by MTases |
| UNG | Uracil-DNA glycosylase; initiates base excision repair of uracil | Repair of deamination lesions; knockout models show increased mutations |
| TDG | Thymine-DNA glycosylase; excises uracil and thymine from mismatches | Backup repair of deamination; studied in mutagenesis |
| MBD4 | Methyl-CpG-binding domain protein 4; glycosylase that removes uracil from CpG sites | Repairs deamination at methylated CpGs; tumor suppressor |
| POLH | DNA polymerase eta; translesion synthesis across uracil lesions | Mutagenesis and repair; relevant to cancer |
| REV1 | Translesion synthesis polymerase; involved in bypass of deaminated bases | Mutagenesis studies |
| Vif | HIV-1 protein that targets APOBEC3G for degradation | Viral evasion of deamination; drug target |
| RPA | Single-stranded DNA-binding protein; facilitates AID and APOBEC3G activity | Accessory factor for deamination |
| Hsp90 | Chaperone that stabilizes AID | Regulation of AID activity |
| PKC | Protein kinase C; phosphorylates AID to regulate activity | Signaling in B cells |
| CUL5 | E3 ubiquitin ligase component; mediates APOBEC3G degradation by Vif | Host-virus interaction |
| CTIP | DNA end resection factor; influences AID targeting | Class-switch recombination |
| XRCC4 | Non-homologous end joining factor; involved in class-switch recombination | Immune diversification |
| LIG4 | DNA ligase IV; NHEJ factor in class-switch recombination | Immune diversification |
How Is DNA cytosine deamination Regulated?
DNA cytosine deamination is regulated at multiple levels. Spontaneous deamination is influenced by temperature, pH, and DNA methylation status, with heat increasing the rate. Enzymatic deamination by AID is controlled by transcriptional regulation, phosphorylation by PKC, and interaction with cofactors such as RPA and Hsp90. APOBEC3G is regulated by HIV Vif, which recruits an E3 ubiquitin ligase complex to degrade it. In bacteria, toxin activity may be controlled by antitoxin proteins or expression timing. Additionally, DNA repair pathways, including base excision repair, determine the biological outcome of deamination events.
DNA cytosine deamination and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| AICDA | Hyper-IgM syndrome, B-cell lymphoma | AID knockout mouse; B-cell specific KO |
| APOBEC3G | HIV-1 restriction, viral evasion | APOBEC3G transgenic mice; HIV infection models |
| UNG | Increased mutagenesis, cancer predisposition | UNG knockout cell lines and mice |
| MBD4 | Colorectal cancer, CpG mutability | MBD4 knockout mice; cancer models |
| DddA | Bacterial toxin, base editing tool | DddA expression in mammalian cells; structural studies |
Cancer and mutagenesis
Unrepaired cytosine deamination leads to C-to-T transition mutations, which are prevalent in cancer genomes. APOBEC3 family members can cause off-target mutations in cancer, contributing to mutational signatures. Defects in base excision repair, such as UNG or MBD4 mutations, increase susceptibility to deamination-induced mutations.
Immunodeficiency and autoimmunity
AID deficiency causes hyper-IgM syndrome, characterized by defective class-switch recombination and somatic hypermutation. Dysregulated AID activity can lead to autoimmunity and B-cell lymphomas.
Viral pathogenesis
APOBEC3G restricts HIV-1, but HIV Vif counteracts it, leading to viral evasion. Other viruses may also be restricted by APOBEC proteins, linking deamination to antiviral defense.
Neurodegeneration and aging
Accumulation of DNA damage, including deamination, is associated with aging and neurodegenerative diseases, though direct evidence for cytosine deamination in neurodegeneration is limited.
From DNA cytosine deamination-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of UNG increase C-to-T mutations? | UNG knockout cell line (e.g., HEK293) |
| What is the structural basis of DddA specificity? | Point mutations in DddA catalytic residues; X-ray crystallography |
| Can AID be tagged for live imaging? | Knock-in of fluorescent tag at AICDA locus |
| Does APOBEC3G overexpression restrict HIV? | APOBEC3G overexpression in T cells |
| What is the strand bias of spontaneous deamination? | Yeast model with transcription reporters |
| Can base editors be improved for therapeutic use? | Directed evolution of adenine base editors (as a related approach) |
How to Study the DNA cytosine deamination Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Single-molecule sequencing | DNA damage and mismatch patterns | Detecting deamination events in genomes |
| Uracil-DNA glycosylase assay | Uracil content in DNA | Quantifying deamination lesions |
| X-ray crystallography | Three-dimensional structure of deaminase-DNA complexes | Mechanistic studies of DddA, SsdA |
| In vitro deamination assay | Enzymatic conversion of cytosine to uracil | Characterizing AID, APOBEC3G, SssI activity |
| Mutational signature analysis | C-to-T transition frequencies | Cancer genomics |
| Yeast transcription reporter | Strand bias of deamination | Transcription-coupled repair studies |
| Directed evolution | Improved base editor activity | Therapeutic genome editing |
| Mass spectrometry | Modified base identification | Detecting uracil and other lesions |
Detection of uracil and deamination events
Uracil in DNA can be detected using uracil-DNA glycosylase-based assays, alkaline gel electrophoresis, or single-molecule sequencing approaches that identify damage patterns. These methods quantify deamination frequency and strand bias.
Structural biology of deaminases
X-ray crystallography and cryo-EM have been used to solve structures of DddA and SsdA bound to DNA, revealing mechanisms of sequence-specific and context-independent deamination. These studies guide inhibitor and editor design.
Enzymatic assays
In vitro deamination assays using recombinant AID, APOBEC3G, or SssI with defined DNA substrates measure catalytic activity and substrate specificity. These assays can be coupled with mass spectrometry or sequencing to identify modified bases.
Mutational signature analysis
Genomic sequencing of tumors or model organisms can reveal C-to-T transition signatures characteristic of cytosine deamination. Computational tools attribute mutational signatures to deamination processes.
How CRISPR Can Be Used to Study GO:0070383 DNA cytosine deamination
Knockout
CRISPR knockout of deaminase genes such as AICDA, APOBEC3G, or UNG allows researchers to assess their roles in mutagenesis, immune diversification, and repair. For example, UNG knockout cells accumulate uracil and exhibit increased C-to-T mutations.
Point Mutation
Introducing point mutations in catalytic residues of DddA or SsdA via CRISPR can dissect their mechanism and specificity. Such models help identify residues critical for deamination activity and guide engineering of base editors.
Knock-in
Knock-in of epitope tags or fluorescent proteins at endogenous loci (e.g., AICDA) enables live-cell imaging and proteomic analysis of deaminases. Knock-in of disease-associated mutations can model their effects on deamination.
Overexpression
Overexpression of APOBEC3G or AID in cell lines is used to study antiviral restriction, mutagenesis, and off-target effects. Overexpression of DddA or SsdA in mammalian cells can induce targeted deamination for genome editing applications.
How EDITGENE Supports DNA cytosine deamination Research
Researchers studying DNA cytosine deamination-related genes often need to determine whether a candidate gene is causally involved in deamination, repair, or downstream mutagenesis. EDITGENE provides comprehensive CRISPR-based services to create precise cellular models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for DNA cytosine deamination research.
Frequently Asked Questions About DNA cytosine deamination
What is DNA cytosine deamination?
DNA cytosine deamination (GO:0070383) is the removal of an amino group from a cytosine residue in DNA, forming a uracil residue.
What genes are involved in DNA cytosine deamination?
Key genes include AICDA (AID), APOBEC3G, DddA, SsdA, and SssI, as well as repair genes like UNG and MBD4.
How does cytosine deamination cause mutations?
If uracil is not repaired before replication, it pairs with adenine, leading to a C-to-T transition mutation.
What is the role of AID in deamination?
AID deaminates cytosine in single-stranded DNA to initiate somatic hypermutation and class-switch recombination in B cells.
How is APOBEC3G involved in antiviral defense?
APOBEC3G deaminates cytosine in retroviral DNA, restricting HIV-1, but is counteracted by viral Vif.
What is the structural basis of DddA deamination?
DddA recognizes double-stranded DNA in a sequence-specific manner and flips the target cytosine for deamination.
Is cytosine deamination biased to a DNA strand?
Yes, in yeast, spontaneous deamination is biased to the non-transcribed strand, likely due to transcription-coupled repair.
How is cytosine deamination repaired?
Uracil is removed by uracil-DNA glycosylase (UNG) and repaired via base excision repair.
Can cytosine deamination be used for genome editing?
Yes, engineered cytidine deaminases are used in base editors for precise C-to-T editing.
What methods study cytosine deamination?
Methods include single-molecule sequencing, uracil-DNA glycosylase assays, X-ray crystallography, and mutational signature analysis.
Conclusion
DNA cytosine deamination (GO:0070383) is a chemically simple but biologically pivotal process that impacts mutagenesis, immunity, and genome editing. Understanding its mechanisms, regulation, and repair is essential for cancer biology, immunology, and therapeutic development. EDITGENE provides the CRISPR tools and services needed to model and dissect this process in relevant cell systems.
References
- 1. Williams JD et al.. 2023. Spontaneous deamination of cytosine to uracil is biased to the non-transcribed DNA strand in yeast.. DNA Repair (Amst) 126:103489 PMID: 37018983
- 2. Gaudelli NM et al.. 2020. Directed evolution of adenine base editors with increased activity and therapeutic application.. Nat Biotechnol 38(7):892-900 PMID: 32284586
- 3. Liu MH et al.. 2024. DNA mismatch and damage patterns revealed by single-molecule sequencing.. Nature 630(8017):752-761 PMID: 38867045
- 4. Yin L et al.. 2023. Structural basis of sequence-specific cytosine deamination by double-stranded DNA deaminase toxin DddA.. Nat Struct Mol Biol 30(8):1153-1159 PMID: 37460895
- 5. Stier I et al.. 2013. Cytosine-to-uracil deamination by SssI DNA methyltransferase.. PLoS One 8(10):e79003 PMID: 24205358
- 6. Yin L et al.. 2025. Structural basis for sequence context-independent single-stranded DNA cytosine deamination by the bacterial toxin SsdA.. Nat Commun 16(1):8841 PMID: 41044082
- 7. Chelico L et al.. 2009. Biochemical basis of immunological and retroviral responses to DNA-targeted cytosine deamination by activation-induced cytidine deaminase and APOBEC3G.. J Biol Chem 284(41):27761-27765 PMID: 19684020
- 8. Ehrlich M et al.. 1986. DNA cytosine methylation and heat-induced deamination.. Biosci Rep 6(4):387-93 PMID: 3527293
